1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow iNKT cells: new trials by email Literature Review of iNKT cells trials Research Report on iNKT cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma GKL-006 Injection, Transarterial chemoembolization (TACE) - Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer | Phase 1 | Active not recruiting | Beijing Gene Key Life Technology Co., Ltd | 6 | 2025-04-03 | 2026-07-20 |
| Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC iNKT cells, IL-2, Tegafur - Hepatocellular Carcinoma | Phase 1 | Completed | Beijing YouAn Hospital | 10 | 2017-04-01 | 2024-09-19 |
Beijing Gene Key Life Technology Co., Ltd (1) · Beijing YouAn Hospital (1)
China (2)
Jun Lu, Director (1)